Tau PET显示Kii半岛ALS/PDC患者tau病理特征性分布
OBJECTIVE: To characterize the distribution of tau pathology in patients with amyotrophic lateral sclerosis/parkinsonism dementia complex on the Kii Peninsula (Kii ALS/PDC) by tau PET using [11C]PBB3 as ligand.…
要点
- [11C]PBB3 PET可显示Kii ALS/PDC患者皮层、白质及脑桥tau沉积。
- 海马及额顶叶白质BP*ND较健康对照增高。
- 额颞顶叶灰质tau沉积与MMSE评分相关。
核心结论
- [11C]PBB3 PET可可视化Kii ALS/PDC的特征性tau病理分布,并与临床表型对应。
研究设计与样本
- 所有受试者接受[11C]PBB3动态PET扫描,并以多线性参考组织模型计算BP*ND。
- 部分受试者还接受了[11C]PiB PET、MRI及认知测试。
主要发现
- 体素比较显示Kii ALS/PDC患者大脑皮层、白质及脑桥基底部(含皮质脊髓束)tau沉积较健康对照增加(未校正p<0.05)。
- 感兴趣区分析显示患者海马及额叶、顶叶白质BP*ND较健康对照增高(p<0.05,Holm-Sidak多重比较)。
- 患者额叶、颞叶、顶叶灰质BP*ND与MMSE评分相关(p<0.05)。
- 所有Kii ALS/PDC患者[11C]PiB(β-淀粉样蛋白)阴性,仅1例边缘阳性。
临床怎么用
- 对于疑诊Kii ALS/PDC的患者,可考虑[11C]PBB3 Tau PET评估特征性tau病理分布。
- Tau PET所见皮层及白质tau沉积有助于与临床表型(认知、运动)联系。
- β-淀粉样蛋白PET阴性支持该病tau病理独立于Aβ沉积。
局限性
- 样本量小(患者5例),未设尸检病理金标准验证。
- 横断面设计无法评估tau沉积与疾病进展的时序关系。
- 统计阈值采用未校正p<0.05,结果需扩大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize the distribution of tau pathology in patients with amyotrophic lateral sclerosis/parkinsonism dementia complex on the Kii Peninsula (Kii ALS/PDC) by tau PET using [11C]PBB3 as ligand. METHODS: This is a cross-sectional study of 5 patients with ALS/PDC and one asymptomatic participant with a dense family history of ALS/PDC from the Kii Peninsula who took part in this study. All were men, and their age was 76 ± 8 (mean ± SD) years. Thirteen healthy men (69 ± 6 years) participated as healthy controls (HCs). Dynamic PET scans were performed following injection of [11C]PBB3, and parametric PET images were generated by voxel-by-voxel calculation of binding potential (BP* ND) using a multilinear reference tissue model. [11C] Pittsburgh compound B (PiB) PET, MRI, and cognitive tests were also performed. RESULTS: A voxel-based comparison of [11C]PBB3 BP* ND illustrated PET-detectable tau deposition in the cerebral cortex and white matter, and pontine basis including the corticospinal tract in Kii ALS/PDC patients compared with HCs (uncorrected p < 0.05). Group-wise volume of interest analysis of [11C]PBB3 BP* ND images showed increased BP* ND in the hippocampus and in frontal and parietal white matters of Kii ALS/PDC patients relative to HCs (p < 0.05, Holm-Sidak multiple comparisons test). BP* ND in frontal, temporal, and parietal gray matters correlated with Mini-Mental State Examination scores in Kii ALS/PDC patients (p < 0.05). All Kii ALS/PDC patients were negative for [11C]PiB (β-amyloid) except one with marginal positivity. CONCLUSION: [11C]PBB3 PET visualized the characteristic topography of tau pathology in Kii ALS/PDC, corresponding to clinical phenotypes of this disease.
引用
- Shinotoh H, Shimada H, Kokubo Y, et al. Tau imaging detects distinctive distribution of tau pathology in ALS/PDC on the Kii Peninsula. Neurology. 2018. PMID: 30530797. doi:10.1212/WNL.0000000000006736
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。